Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
Jordan J. Feld, Christopher Kandel, Mia J. Biondi, Robert Kozak, Muhammad Atif Zahoor, Camille Lemieux, Sergio Borgia, Andrea K. Boggild, Jeff Powis, Janine McCready, Darrell H. S. Tan, Tiffany Chan, Bryan Coburn, Deepali Kumar, Atul Humar, Adrienne K. Chan, Braden O’Neil, Seham Noureldin, Joshua Booth, Rachel Hong, David Smookler, Wesam Aleyadeh, Anjali Patel, Bethany Barber, Julia Casey, Ryan Hiebert, Henna Mistry, Ingrid Choong, Colin Hislop, Deanna M. Santer, D. Lorne Tyrrell, Jeffrey S. Glenn, Adam J. Gehring, Harry L.A. Janssen, Bettina E. Hansen
Topics & Concepts
MedicinePlaceboClinical endpointInternal medicineAsymptomaticViral loadRandomized controlled trialGastroenterologyImmunologyVirusPathologyAlternative medicineCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchRespiratory viral infections research